Cite
Kilinc MO, Santidrian A, Minev I, et al. The ratio of ADSCs to HSC-progenitors in adipose tissue derived SVF may provide the key to predict the outcome of stem-cell therapy. Clin Transl Med. 2018;7(1):5doi: 10.1186/s40169-018-0183-8.
Kilinc, M. O., Santidrian, A., Minev, I., Toth, R., Draganov, D., Nguyen, D., Lander, E., Berman, M., Minev, B., & Szalay, A. A. (2018). The ratio of ADSCs to HSC-progenitors in adipose tissue derived SVF may provide the key to predict the outcome of stem-cell therapy. Clinical and translational medicine, 7(1), 5. https://doi.org/10.1186/s40169-018-0183-8
Kilinc, Mehmet Okyay, et al. "The ratio of ADSCs to HSC-progenitors in adipose tissue derived SVF may provide the key to predict the outcome of stem-cell therapy." Clinical and translational medicine vol. 7,1 (2018): 5. doi: https://doi.org/10.1186/s40169-018-0183-8
Kilinc MO, Santidrian A, Minev I, Toth R, Draganov D, Nguyen D, Lander E, Berman M, Minev B, Szalay AA. The ratio of ADSCs to HSC-progenitors in adipose tissue derived SVF may provide the key to predict the outcome of stem-cell therapy. Clin Transl Med. 2018 Feb 07;7(1):5. doi: 10.1186/s40169-018-0183-8. PMID: 29417261; PMCID: PMC5803165.
Copy
Download .nbib